PubHealth.infoŽ (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.infoŽ, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.infoŽ presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.infoŽ regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.infoŽ is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.infoŽ (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 68: Articles 33501-34000 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Public welfare and family planning: an empirical study of the "brood sow" myth.
  2. Pulmonary arterial thrombosis during oral contraception. Treatment with urokinase) [Thrombose de l'artere pulmonaire sous traitement contraceptif hormonal. Traitement par l'urokinase.]
  3. The purpose of family planning. (Letter to the editor)
  4. Pyelonephritis as a complication of hormonal contraception. (experimental study) [Pielonefrit kak oslozhnenie gormonalnoi kontratseptsii eksperimentalnoe issledovanie.]
  5. Pyridoxal, vitamin B12 and folate metabolism in women taking oral contraceptive agents.
  6. Radioimmunoassay of contraceptive steroids. 2. Synthesis of 6,7-tritiated-mestranol and ethinylestradiol of high specific activity.
  7. Ramifications of common problems and unmet needs of family planning agencies in the Philippines.
  8. A randomized contraceptive trial comparing a daily progestogen with a combined oral contraceptive steroid.
  9. Real costs of delivering family planning services. Implications for management.
  10. Research in human reproduction and family planning.
  11. Research on the biomedical aspects of fertility regulation and on the operational aspects of family planning programmes.
  12. Research, production and marketing in industry. (Contraceptives)
  13. Restovar, a new combined oral contraceptive with a low estrogen content. [Restovar un nouveau contraceptif oral combine a faible teneur en oestrogene.]
  14. Results obtained with the simple Lippes loop, as an intrauterine contraceptive. [Resultados obtenidos con el asa de Lippes simple, como anticonceptivo intrauterino.]
  15. Results of bacteriological studies of the contents of the uterine and vaginal cavities in women who use intrauterine contraceptives. [Rezultati bakteriologichnikh doslidzhen vmistu poroznnini matki u zhinok, yaki koristuyutsya vnutrimatkovimi kontratseptivami.]
  16. Return of fertility following discontinuation of three types of contraceptive methods.
  17. Reversible contraceptive action of testosterone in males.
  18. A review of contraceptive methods.
  19. A review of Family Health's latest evaluation of the demographic impact of the Louisiana Family Planning Program.
  20. Review of longitudinal data on the impact of family planning in 22 sample areas.
  21. A review of methods for second trimester termination of pregnancy. Experience at King's College Hospital in relation to method of termination and contraceptive follow up.
  22. A review of the United Nations' programmes and activities in family planning/the contribution of social welfare to the programme in the Asian region.
  23. Revisits to the family planning clinic.
  24. Rice or rubber. (Food vs. contraception)
  25. Rifampicin and oral contraception. (Letter to the editor)
  26. Rio Grande do Norte: community participation in family planning. [Rio Grande do Norte: Participacao da comunidade no planejamento familiar.]
  27. Risks associated with oral contraceptive use.
  28. Risky birth control: Depo-Provera.
  29. Role of cervical cytology in family planning.
  30. The role of doctors in family planning in Canada.
  31. The role of governmental, international, and voluntary agencies in population dynamics and family planning.
  32. Role of industries in family planning.
  33. The role of interspousal communication in adoption of family planning methods: a couple approach.
  34. Role of management institutes in the family planning activities.
  35. Role of medical students in community service with respect to population dynamics and family planning.
  36. The role of nurses in family planning.
  37. The role of practitioners of indigenous medicines in the family planning programme - a study in three states (India)
  38. Somali Democratic Republic. (Family planning)
  39. Some aspects of the use of hormonal contraceptives. [Deyaki aspekti zastosuvannya gormonalnikh kontratseptiviv.]
  40. Some considerations in the generation and use of management information in the national family planning program.
  41. Some considerations of incentives and disincentives in the promotion of family planning.
  42. Some cultural and socio-psychological factors affecting male family planning decision-making behavior in rural Pakistan: an analysis of supporters and opponents.
  43. Some dimensions of population and family planning: goals and means.
  44. Some issues and a checklist relative to the medical evaluation of family planning clinics.
  45. Some metabolic actions and possible toxic effects of hormonal contraceptives in animals and man. (Presented at the meeting on Pharmacological Models to Assess Toxicity and Side Effects of Fertility Regulating Agents, Geneva, September 17-20, 1973)
  46. Some mythology of birth control.
  47. Some observations on family planning prospects in Sierra Leone.
  48. Some observations on the gathering and use of family planning program statistics in Costa Rica, El Salvador, and Nicaragua.
  49. Some religious views on family planning.
  50. Some sociological considerations in promoting family planning programmes.
  51. Some techniques for measuring the impact of contraception.
  52. Some thoughts about the attitude concept in relation to family planning.
  53. Some thoughts on the moral aspect of family planning.
  54. The source of the contraceptive polypeptide influencing ovarian function.
  55. South-east Asia: methods in postpartum family planning.
  56. Spanish women and birth control. [La mujer espanola y el control de la natalidad.]
  57. Special problems in toxicity testing of long acting depot contraceptives. (Meeting on Pharmacological Models to Assess Toxicity and Side Effects of Fertility Regulating Agents, Geneva, September 17-20, 1973)
  58. Special requirements for testing post-coital contraceptives.
  59. Specialized vs. combined clinics: patterns of delivery of family planning services.
  60. Specificity of two commercial acid phosphatase determination kits with respect to feminine hygiene products and vaginal contraceptives.
  61. Speech concerning natural family planning]
  62. Spermicidal contraceptives as human teratogens.
  63. Spontaneous rupture of the liver in patient using contraceptive pills.
  64. The spread of the family planning idea through adult education activities in Indonesia.
  65. Squamous metaplasia of the endometrium in women with an intrauterine contraceptive device: follow-up study.
  66. Sri Lanka is ripe for family planning.
  67. Staff preparation for family planning communication roles in the Philippines and Malaysia: case study report No. 4.
  68. Staff: planning, selection, training and development for family planning work.
  69. State clings to archaic contraceptive law. (Letter to the editor)
  70. The state of family planning in the Philippines.
  71. The state of organized family planning programs in the United States, 1973.
  72. Statesman's guide to the contraceptive pill. (Draft)
  73. 'Family' planning and the single university student.
  74. 3 of 143 conceive in test of postcoital contraceptive.
  75. 5-thio-D-glucose: a unique male contraceptive.
  76. The ABCs of contraception. [L'ABC de la contraception.]
  77. Abortion and family planning in the Soviet Union: public policies and private behaviour.
  78. Abortion compared with contraception. (Letter to the editor)
  79. Abortion compared with contraception. (Letter to the editor)
  80. Abortion in relation to family planning.
  81. The abortion law reviewed -- free contraception -- angry angels.
  82. Abortion, contraception and ethics.
  83. Abortive and contraceptive vegetal agents. [Agentes vegetales abortivos y contraceptivos.]
  84. Acceptability of injectable contraception in the Philippines.
  85. The Acceptance of a family planning clinic by recently delivered teen-agers.
  86. Accuracy of recall of histories of oral contraceptive use.
  87. Achievements of National Family Planning Programs.
  88. Action of oral contraceptives on the inner ear: clinical and audiometric aspects. [Action des contraceptifs oraux sur l'oreille interne: aspects cliniques et audiometriques.]
  89. Action planning for family planning.
  90. Acute ophthalmologic complications during the use of oral contraceptives.
  91. Acute pancreatitis and hyperlipidemia with oral contraceptives) [Pancreatite aigue et hyperlipemie sous contraceptifs oraux.]
  92. Acute transient polyneuritis associated with oral contraception. (Letter to the editor)
  93. Administration in family planning made effective.
  94. Administrative models for the high level planning and coordination of government population and family planning programs in the near east and Africa. (First Regional Population Conference, Beirut, Lebanon, February 18-March 1, 1974)
  95. Administrative relationships between maternal and child health programs and family planning programs in health departments-1973.
  96. The adoption of an innovation in a developing country: The case of family planning in Indonesia.
  97. Adrenocortical function of patients using oral contraceptives.
  98. Adult education and family planning in Home Economics Division, Department of Agriculture, Laos.
  99. Adult education and family planning in Singapore.
  100. Adult education and family planning in Thailand.
  101. Adult education and family planning in the Philippines.
  102. Adult education and family planning, the Malaysia experience.
  103. Adult education in family planning (Case studies)
  104. Adult education in Indonesia and family planning.
  105. Advances and development of norgestrel-containing contraceptives: an incremental dosage regimen (50/50, 125/50)
  106. Adverse effects of contraceptives. [Medikamentell terapi i praksis.]
  107. Adverse effects of oral contraceptives. [Bivirkninger ved-bruk af orale kontraceptiva.]
  108. Advertising male contraceptives.
  109. African youths: their knowledge, attitudes and practices toward family planning.
  110. Age at marriage, family planning practices, and other variables as correlates of fertility in Korea.
  111. Agena: a new topical contraceptive agent with antiseptic action. [L'Agena: un nuovo contracettivo locale ad azione antisettica.]
  112. Agriculture based family planning programs.
  113. Aid for family planning in Egypt.
  114. Albay mobile service -- family planning to the barrios.
  115. Alteration of some human coagulation components by hormonal contraceptives.
  116. The alteration of surface change characteristics of the vascular system by oral contraceptive steroids.
  117. Amenorrhea and infertility after the use of oral contraceptives.
  118. Amenorrhea and infertility associated with oral contraception.
  119. Amenorrhoea and infertility associated with oral contraception.
  120. America. (Family planning nurse-clinicians)
  121. Analysis of Family planning patterns as a new instrument of fertility prediction.
  122. An analysis of the incidence and prevalence of cervical dysplasia and carcinoma-in-situ with respect to contraceptive use.
  123. Analytical assessment of implementation systems for family planning programmes: frame of reference for national studies.
  124. Annexes. (Family planning and communication)
  125. Announcing an oral contraceptive...(Ovrette). (Advertisement)
  126. Annual report for 1973. (Family planning)
  127. Another kind of family planning.
  128. Anti-epileptic drugs and failure of oral contraceptives. (Letter)
  129. Antiepileptic drugs and congenital malformations. Interaction between antiepileptic drugs and contraceptives? [Antipileptika ig kongenitte misdannelser. Interaktion mellem antipilep tika og p-piller?]
  130. Antithrombin 3 levels and oral contraceptives.
  131. Appearance of a folate binder in leukocytes and serum of women who are pregnant or taking oral contraceptives.
  132. Appendix B. The relationship between program inputs, socio-economic levels, and family planning performance: a regression analysis.
  133. Applications of computerized stochastic models of human reproduction and population growth in family planning evaluation.
  134. Applications of terminating nonhomogeneous renewal processes in family planning evaluation.
  135. An appraisal of psychology research in family planning.
  136. An approach to illness measurement in a rural community: a questionnaire sample survey of households in the population of the Danfa Comprehensive Rural Health and Family Planning Project in Ghana.
  137. Argentina bans birth control.
  138. Argentina bans promotion of birth control.
  139. Arterial thrombosis, smoking, and oral contraceptives.
  140. Asian Regional Seminar on Management of Family Planning Programmes, Singapore, November 5-8, 1974.
  141. An assessment of contraceptive technology: current status and potential developments.
  142. Assessment of incremental dosage regimen of combined oestrogen-progestogen oral contraceptive.
  143. Assessment of tryptophan metabolism and vitamin B6 nutrition in pregnancy and oral contraceptive users.
  144. Association of oral contraceptives and congenital limb-reduction defects.
  145. Assumption for family planning among mothers. [Voraussetzungen fur die Familienplanung bei Muttern.]
  146. Attitude to family planning in an Aurangabad slum.
  147. Attitude, value orientation of users and non-users of family planning in Pakistan.
  148. Attitudes and evolution of the position of treatment personnel in a mixed psychiatric service regarding contraception for patients. 2 successive surveys of clinic personnel. [Attitudes et evolution de la position des soignants vis-a-vis de la contraception des malades dans un service psychiatrique mixte. A propos de deux enquetes successives aupres du personnel infirmier.]
  149. Attitudes of armed forces' personnel towards family planning.
  150. The attitudes of Philippine family planning physicians towards sterilization.
  151. Attitudes to contraception.
  152. Attitudes toward premarital sex and family planning for single-never-pregnant teenage girls.
  153. Attitudes toward sexual education, the use of contraceptive methods and abortion. [Actitudes hacia la educacion sexual, el uso de metodos anticonceptivos y aborto.]
  154. Australia (Family planning)
  155. Australian birth control to go on trial in India.
  156. Australian scientists develop male contraceptive.
  157. Auxiliaries and family planning.
  158. Availability of family planning services: the key to rapid fertility reduction.
  159. Bacteriuria and oral contraceptives.
  160. Bacteriuria and oral contraceptives.
  161. Bangkok woos its rural women to practice family planning.
  162. The Barbados Family Planning Association and fertility decline in Barbados.
  163. Barriers against the acceptance of family planning programmes in Asia.
  164. Barriers between contraceptive services and the consumer.
  165. Basic concepts in contraceptive service statistics: a data collection system for the family planning program.
  166. Before and after mass media experiment: Impact of two alternative motivational campaigns on knowledge, attitude and practice of family planning.
  167. The behavioural factors in family planning adoption.
  168. Benign cholestatic jaundice of pregnancy and benign cholestatic jaundice from oral contraceptives.
  169. Benign hepatoma and oral contraceptives.
  170. Benign hepatoma in a young woman on contraceptive steroids.
  171. Benign hepatomas and oral contraceptives.
  172. Beyond family planning: options for international agencies.
  173. Bibliography on human reproduction, family planning and population dynamics: annotated articles and unpublished work in the South-East Asia Region, October 1973-March 1974.
  174. Bibliography on human reproduction, family planning and population dynamics: annotated articles and unpublished work in the South-East Asia Region: steroid contraception (including review of current status)
  175. Biochemical and contraceptive effects of an intravas device in the rat.
  176. The biochemistry of contraception.
  177. The biological consequences of family planning.
  178. Birth control and family planning.
  179. Birth control and the private physician: the view from Los Angeles.
  180. Birth control and unmarried young women.
  181. Birth control as a weapon of imperialism.
  182. Birth control becomes a national cause.
  183. Birth control by continuous low dose progestagens. [Controle de la fertilite par l'administration continue de progestagenes a faible dosage.]
  184. Birth control clinic for teenagers.
  185. Birth control clinic: education and clinical services.
  186. Birth control in Canada: 5 years of legitimacy.
  187. Birth control in China: a research bibliography.
  188. Birth control in nineteenth-century America: a view from three contemporaries.
  189. Birth control in Runcorn and Coalville: a study of the F.P.A. campaign.
  190. Birth control in the Third World - is it Neo-colonialism in disguise?
  191. Birth control methods in psychiatry. [Moyens de controle des naissances en psychiatrie.]
  192. The birth control movement and oral contraceptives in the college population.
  193. The birth control movement on the Chinese mainland.
  194. Birth control planning.
  195. Birth control, sterilization, and abortion.
  196. Birth control.
  197. Birth control: an essential freedom.
  198. Birth control: continuation of discussion on draft legislation. [Regulation des naissances: suite de la discussion d'un projet de loi.]
  199. Birth control: its lawfulness and methods.
  200. Birth defects and oral contraceptives.
  201. Birth of the FPOP (Family Planning Organization of the Philippines)
  202. Blood coagulation and platelet-function parameters before and during parenteral administration of medroxyprogesterone acetate as a contraceptive agent.
  203. Blood pressure during estrogen + progestin contraception after pregnancy-induced hypertension.
  204. Blood pressure in women taking oral contraceptives.
  205. Bolivia firms up plans to launch nation's first family planning effort.
  206. Bolivia prepares for its national family planning program. [Bolivia se prepara para su programa nacional de panificacion de la familia.]
  207. A bookshelf on family planning.
  208. The BRAC heath care, preventive medicine and family planning services program.
  209. Breast feeding and family planning.
  210. Breast feeding and family planning. [editorial]
  211. Brief study of family planning in Islam.
  212. A brief study on Islam's view on planned parenthood.
  213. Building practical evaluation of communication and education into family planning/population programmes.
  214. By-products of oral contraception.
  215. C-Film as a contraceptive.
  216. C-Film as a contraceptive. (Letter to the editor)
  217. C-Film: a new spermicidal contraceptive.
  218. A campaign to repeal legal restrictions on nonprescription contraceptives: the case of New York.
  219. CANADA. (FAMILY PLANNING)
  220. Cancer screening by cytology in a large urban family planning program.
  221. Cardiovascular dynamics in women during the menstrual cycle and oral contraceptive therapy.
  222. Case study of action by FICCI and its affiliates to promote family planning in industry.
  223. A case-control study investigating the relationship of low-estrogen dose oral contraceptives to thromboembolism.
  224. A case-control study of the epidemiology of benign breast diseases with reference to oral contraceptive use.
  225. Cases and material on family planning law and population policy.
  226. Center for Disease Control: annual summary of family planning services 1972.
  227. Central retinal vein thrombosis in a woman on contraceptive pills.
  228. Cerebral vascular accidents and oral contraceptives. [Accidents vasculaires cerebraux et contraceptifs oraux.]
  229. Cerebrovascular accidents observed in young women using oral contraceptives (Abstract only) [Les accidents vasculaires cerebraux observes chez les femmes jeunes utilisant les contraceptifs oraux.]
  230. Cervical adenocarcinoma in a woman on long-term contraceptives.
  231. Cervical perforation by the Copper T intrauterine contraceptive device.
  232. The challenging role of communications in family planning programs.
  233. A chance to lead: the hospital's role in contraception.
  234. Change in glucose and insulin after 6 months' treatment with the oral contraceptive Demulen.
  235. Changes in family planning attitudes and experiences of seminary student s: a ten-year assessment.
  236. Changes in plasma renin substrate, activity, and concentration and in plasma and urinary aldosterone in normotensive and hypertensive women before and after oral contraceptive use.
  237. Changes in the characteristics of new female contraceptive patients served by the Planned Parenthood of America, 1966-June 30, 1973.
  238. Changes in the menstrual pattern during use of hormonal contraceptives. [Modificacoes do padrao menstrual com o uso de anticoncepcionais hormonais.]
  239. Changes in the use of oral contraception and other methods of fertility control between 1968 and 1971.
  240. Changing profile of a family planning clinic.
  241. Charges for contraceptives.
  242. Chauvinism in family planning persists despite women's roles.
  243. Chicago Planned Parenthood's Teen Scene: a sociological study for participants.
  244. Child health - a motivating force for family planning.
  245. China stands out in birth control, family planning.
  246. China's family planning programme spells success.
  247. China. (Family planning)
  248. Choice of a contraceptive method depending on anatomical and physiological variables of persons who ask for contraception. [Choix dune methode contraceptive en fonction des varietes anatomiques et physiologiques des personnes venant demander la contraception.]
  249. Choice of contraceptives.
  250. Choice of contraceptives. (Letter to the editor)
  251. Choosing contraceptives according to need.
  252. Choosing the best mode of contraception.
  253. The classification of patients requiring hormonal contraception.
  254. Client-centered systems approach to management improvement in the family planning programs of Central America.
  255. The clinic and information flow: educating the family planning client in three Latin American countries.
  256. Clinical and endocrinological results with the use of continuous microdose of megestrol acetate as a contraceptive.
  257. Clinical and in-vivo experiences with a new local contraceptive. [Klinische und In-vivo-Erfahrungen mit einem neuen lokal an anwendbaren Antikonzipiens.]
  258. Clinical aspects of medroxyprogesterone injection as a contraceptive method. [Aspectos clinicos so uso da medroxiprogesterona injetavel como meio anti-conceptional.]
  259. Clinical aspects of the use of injectable medroxyprogesterone (MPA) as a contraceptive. [Aspectos clinicos do uso da medroxiprogesterona injetavel como meio anticoncepcional.]
  260. Clinical assessment of a low-dose oestrogen, low-dose progestogen combined oral contraceptive.
  261. The clinical delivery of family planning services in Costa Rica 1973: country program description source document.
  262. Clinical evaluation of a new low dose progestagen-only contraceptive containing cingestol.
  263. Clinical evaluation of an oral progestin contraceptive, R-2323, 5 mg, administered at weekly intervals.
  264. Clinical experience with a once-a-month oral contraceptive pill: Quingestanol and Quinestrol.
  265. Clinical experience with the LEM, an intrauterine contraceptive device.
  266. Clinical research with ovostat -- a combined oral contraceptive with a small lynestrenol dose. [Klinische Untersuchung mit Ovostat -- einem kombinierten oralen Kontrazeptivum mit einer niedrigen Dosis Lynestrenol.]
  267. Clinical screening for breast disease in women attending a family planning clinic.
  268. Clinical studies on the low-dosage noregestrel-ethinyl estradiol combination as a long term oral contraception. (Abstract only)
  269. Clinical trial with a new low oestrogen combined oral contraceptive.
  270. Coalville -- an experiment in family planning.
  271. Coital frequency and contraception.
  272. College students relying more on pill, IUD: availability of contraception seen as factor.
  273. Colombia: Stages of family planning adoption. 1964-1969.
  274. Colorimetric determination of ethinyl estradiol in oral contraceptive formulations.
  275. Colposcopic findings in contraception.
  276. Combination of hormones seems promising as male contraceptive in human trials.
  277. Comments on the use of MPA 150 in a family planning center) [Commentaires sur l'utilisation du MPA 150 dans un centre de planning familial.]
  278. Commercial distribution of contraceptives in Afghanistan: actual and potential use of the pharmaceutical marketing system.
  279. Communication and information about family planning.
  280. Communication and population socialization among youth: communication behavior and family planning information.
  281. Communication in support of population/family planning and development.
  282. Communication methodologies and evaluation techniques in the model family planning project, Kusestan, Iran.
  283. Communication research in family planning: an analytical framework.
  284. Communication support for family planning programmes: the potentialities for folk media in Indonesia and the problems involved in pre-testing and evaluation.
  285. Community based family planning: Indian pills.
  286. Community family planning services.
  287. Comparative effects of silk and copper intra-uterine contraceptive devices on the uterine horns of rat.
  288. A comparative randomized double-blind study of the copper-T200 and copper-7 intrauterine contraceptive devices with modified insertion techniques.
  289. A comparative study of adverse effects of oral contraceptives.
  290. Comparative study of adverse effects of oral contraceptives. [Letter]
  291. A comparative study of decision strategies on content and utilization of family planning radio programs in Taiwan and Pakistan. A preliminary report to the East-West Communication Institute, East-West Center.
  292. A comparative study of the effectiveness of a family planning program in rural Korea. (Doctorate, University of Michigan, School of Public Health, 1968)
  293. A comparative study of the safety and efficacy of postabortal intrauterine contraceptive device insertion.
  294. Comparative study of world law on contraceptives: revised and updated.
  295. A comparative study on the administration of family planning programmes in the ESCAP region for the national study of the Republic of Korea: organizational determinants of performance in family planning services.
  296. Comparison of changes in erythrocytic and resin tests induced by the use of femigen-forte and femigen (polfa) preparations as contraceptives. [Porownanie zmian w tescie krwinkowym i zywicowym wywolanych stosowaniem preparatow femigen-forte i femigen (polfa) dla celow antykoncepcyjnych.]
  297. Comparison of continuation rates in oral contraceptive and I.U.C.D. users.
  298. A comparison of intrauterine contraceptive devices and oral contraceptives in the nullipara.
  299. A comparison of the histologic patterns of cervical intraepithelial neoplasia in women using oral steroid, diaphragm and other contraceptives.
  300. A comparison of the results of family planning KAP surveys in Haryana and Tamil Nadu, India.
  301. Compatibility of oral contraceptive with anti-tubercular chemotherapy in female pulmonary tuberculosis patients.
  302. Compliance with contraceptive regimens.

     

  303. Complications noted during the course of treatment with oral contraceptives: results of a national survey. [Accidents observes au cours de la prise de contraceptifs oraux: resultats d'une enquete nationale.]
  304. Con-fer: contraception plus iron.
  305. Conception control in family planning.
  306. Conception, birth and contraception: a visual presentation. 2nd Edition.
  307. Conclusion on the research on family planning: Latin America (supplement)
  308. Confrontation of experience and perspectives on the functioning of family planning centers. [Confrontation d'experiences et perspectives sur le fonctionnement des centres d'orthogenie.]
  309. Consultant gynaecologists and birth control.
  310. Consultant's recommendation for birth control pills.
  311. Consumer behavior in the contraceptive market.
  312. Continuation and termination of contraceptive practice. (Family planning in Thailand)
  313. Continuation of contraceptive practice in Thailand: the 1971 follow-up survey.
  314. Continuing education and training/non-social work personnel in family planning.
  315. Continuous administration of lynestrenol as a contraceptive. [Linestrenol administrado en forma continua como anticonceptivo.]
  316. Continuous low-dose progestagen oral contraceptives.
  317. Continuous microdose (0.3 mg) quingestanol acetate as an oral contraceptive agent.
  318. Contraception (In Ireland)
  319. Contraception - progress and propaganda in Italy.
  320. Contraception advised until after laparoscopic tubal ligation.
  321. Contraception after abortion.
  322. Contraception and abortion.
  323. Contraception and abortion.
  324. Contraception and abortion: the rule and the exception. [La contraception et l'avortement: la regle et l'exception.]
  325. Contraception and birth control.
  326. Contraception and epilepsy. [Contraception et epilepsie.]
  327. Contraception and fertility change in the International Postpartum Program.
  328. Contraception and sexual behavior in the later postpartum. [Befragung uber Antikonzeption und uber das sexuelle Verhalten im Spatwochenbett.]
  329. Contraception and the Irish constitution.
  330. Contraception chez les jeunes femelles bovines. 1re note. (Contraception in young heifers. Preliminary note.)
  331. Contraception for minors: Report of a physician survey.
  332. Contraception for nulliparas. [La contraception chez la nullipare.]
  333. Contraception immediately after abortion.
  334. Contraception in diabetic patients.
  335. Contraception in psychiatric hospitals. [La contraception dans les hopitaux psychiatriques.]
  336. Contraception or family planning.
  337. Contraception orale et etats depressifs induits. (Oral contraception and induced depressive states)
  338. Contraception using the intrauterine device. Techniques, indications, complications. [La contraception par sterilet ou dispositif intra-uterin. Techniques, indications, complications.]
  339. Contraception with low dose of lynestrenol, exlutona. [Kontraception ved lavdosis af gestagenet lynestrenol, exlutona.]
  340. Contraception.
  341. Contraception.
  342. Contraception.
  343. Contraception: a survey of the literature: past, present, and future.
  344. Contraceptive Agents and the exocrine pancreas. [Ovulationshemmer und exokrines Pankreas.]
  345. Contraceptive choice and cervical cytology.
  346. Contraceptive development.
  347. Contraceptive distribution in Brazil.
  348. Contraceptive distribution in the commercial sector of Turkey.
  349. Contraceptive education: a self-instructional course.
  350. The contraceptive effect of the IUD and its continuance.
  351. The contraceptive efficacy of 10 mg or 25 mg of norethindrone given orally on Day 15-22 of the human menstrual cycle.
  352. Contraceptive failure linked to age, intent: although pill IUD most effect methods.
  353. Contraceptive information - a few aspects of social information. [Preventivmedelinformation - nagra aspekter pa social information.]
  354. Contraceptive information - an activity in progress. [Preventivmedelsradgivning - verksamhet i utveckling.]
  355. Contraceptive knowledge, attitudes, and practice. (Family planning in Thailand)
  356. Contraceptive methods used. [Metodos anticonceptivos usados.]
  357. Contraceptive pamphlets in Colombian drugstores.
  358. The contraceptive pill -- current status.
  359. Contraceptive pills and cataracts. [Pilules contraceptives et cataracte.]
  360. Contraceptive practice before and after out-patient termination of pregnancy.
  361. Contraceptive practices in Finland in 1971.
  362. Contraceptive practices of white unmarried university students: the significance of four years at one university.
  363. The contraceptive situation in the Irish Republic.
  364. Contraceptive sterilization varies by region: female rate highest in South, male in West.
  365. Contraceptive technology: 1974-1975.
  366. Contraceptive testing in India: an editorial comment.
  367. Contraceptive therapy following therapeutic abortion.
  368. Contraceptive use before and after abortion.
  369. Contraceptive use higher following abortion than before; better methods employed.
  370. Contraceptives and health.
  371. Contraceptives at easy reach.
  372. Contraceptives available by prescription.
  373. Contraceptives. [Contraceptivos.]
  374. Contraceptives: a million recruits.
  375. Contraceptives: truth and falsehood. [Los anticonceptivos: verdad y mentira.]
  376. Contribution of low doses in oral contraception. [L'apport des faibles doses dans la contraception orale.]
  377. The contribution of the nurse in family planning.
  378. Control of morbidity associated with saline abortion. (Twelfth Annual Scientific Meeting of the Association of Planned Parenthood Physicians, Memphis, Tennessee, April 16-17, 1974)
  379. Conventional methods and local methods of contraception. [Les methodes classiques et les methodes locales de contraception.]
  380. Conventional methods of contraception: condom, diaphragm, and vaginal foam.
  381. The conventional term family planning, or planned parenthood.
  382. Cooperation in the area of birth control.
  383. Coordinated studies of the effects of oral contraceptives.
  384. Coordinated studies of the effects of oral contraceptives.
  385. Copper intrauterine contraceptive devices.
  386. Copper levels in women using intrauterine devices or oral contraceptives.
  387. Copper particles from intrauterine contraceptive device.
  388. Copper-T-Kabi intrauterine contraceptive device.
  389. Correlates of female powerlessness: parity, methods of birth control, pregnancy.
  390. Correlation of various clinical parameters with glucose tolerance test in women using oral contraceptives.
  391. Correlations among women's views of contraception, anxiety, creativity, and equalitarianism measures.
  392. Cost analysis of family planning delivery systems.
  393. Cost effectiveness in the evaluation of family planning programmes.
  394. The cost of contraceptive sterilization.
  395. Costa Rica. (Family planning)
  396. Couple communication in the contraceptive decision making of Jamaican women.
  397. Criteria for the introduction of new technologies for abortion and contraception.
  398. The CU-7: a metallic copper intrauterine contraceptive device.
  399. Culture and communication: an argument for audience involvement in family planning materials production.
  400. A cumulative total contraceptive method acceptance reported by developing countries and an estimate of current use. (Abstract only)
  401. Current aspects of contraceptive methods. [Aspects actuels des methodes de la contraception.]
  402. Current legislation on contraception. [Les dispositions legales actuelles de la contraception.]
  403. Current legislation on contraception. [Les dispositions legales actuelles de la contraception.]
  404. Current status of contraceptive steroids and the intrauterine device.
  405. Curricula for management training programmes in family planning.
  406. Cytogenetic evaluation of patients in relation to the use of oral contraception.
  407. Cytological findings during oral contraception. [Zytologische Befunde unter oralen Kontrazeptiva.]
  408. Danfa Comprehensive Rural Health and Family Planning Project - Ghana: research design.
  409. Danfa Comprehensive Rural Health and Family Planning Project: Ghana. Annual progress report January-December 1974.
  410. The Danfa, Ghana, rural health and family planning project.
  411. Data and analysis for 1974 revision of DHEW five-year plan for family planning services.
  412. Decision making about family planning at family level.
  413. Decision-making and information systems in the management of family planning programs. (Report of the Regional Family Planning Management Seminar for Central America and Panama, San Jose, Costa Rica, June 2-7, 1974)
  414. Delivery systems for family planning.
  415. Demographic characteristics and knowledge of family planning.
  416. Demographic effects of family planning. [Demographische Auswirkungen der Familienplanung.]
  417. The demographic problem and birth control. [Il problema demografico e la limitazione delle nascite.]
  418. The demography of contraceptive practice. (Family planning in Thailand)
  419. Depo-Provera -- the injectable contraceptive.
  420. Depo-provera as a long-term contraceptive. [Le Depo-provera en contraception retard.]
  421. Depression induced by oral contraception and the role of vitamin B6 in its management.
  422. Depression, oral contraceptives, and pyridoxine, vitamin B6. [Deprsjon, p-piller og-pyridoksin, vitamin B6.]
  423. Depressive illness and oral contraceptives. A study of urinary 5-hydroxyindoleacetic acid excretion.
  424. Description of the rural family planning program. [Descripcion del programa rural de planificacion familiar.]
  425. Design of early clinical trials for new contraceptive methods.
  426. Designing a program in family planning.
  427. Desire for a child and contraception. [Desir d'enfant et contraception.]
  428. Developing statewide family planning programs: a planning handbook. Vol. 1.
  429. Developing statewide family planning programs: a planning handbook. Vol. 2 Workbook.
  430. Development of an educational model in family planning.
  431. The development of contraceptive methods in Indonesia.
  432. The development of family planning in New Zealand.
  433. The development of nutrition/family planning programs. What are the pre-considerations?
  434. Development of ovarian follicles correlated to levels of serum FSH and LH during long-term oral contraception.
  435. Development of porphyria cutanea tarda after oral contraceptive therapy. Case report. [Vznik Porphyria cutanea tarda po peroralni antikoncepcni terapii. Kasuisticke sdeleni.]
  436. Device and technique for blocking the Fallopian tubes: a method for reversible contraceptive sterilization.
  437. DHEW analysis: small projects very costly, age, location also affect family planning program costs.
  438. Diabetes and oral contraceptives. [Diabetes y contraceptivos orales.]
  439. The different forms of contraception. [Les differentes formes de contraception.]
  440. Differentials in contraceptive use-effectiveness in the Philippines.
  441. Diffusion of family planning innovations: theoretical and practical issues.
  442. Direct mail and information diffusion: family planning.
  443. Discussions about family planning and international co-operation.
  444. Distance and diffusion of family planning adopters: a view from a Philippine municipality.
  445. Distribution and supervision of oral contraceptives [letter]
  446. Distribution and supervision of oral contraceptives [letter]
  447. Distribution and supervision of oral contraceptives (Letter to the editor)
  448. Distribution and supervision of oral contraceptives.
  449. Distribution and supervision of oral contraceptives. (Letter to the editor)
  450. Distribution of contraceptives by non-doctor personnel.
  451. Distribution of contraceptives in the commercial sector of selected developing countries. Summary report.
  452. Distribution of contraceptives: a pilot study of 63 pharmacies in the San Salvador metropolitan area. [Comercializacion de anticonceptivos: estudio piloto en 63 farmacias del area metropolitana de San Salvador.]
  453. Distribution: a democratic approach (contraceptives)
  454. Disturbance of tryptophan metabolism and its correction during hormonal contraception.
  455. Do you have any reports of birth defects or other adverse effects associated with the use of oral contraceptives or other sex-hormone preparations during pregnancy?
  456. Doctors survey of oral contraceptive use, July 1973.
  457. Does the Qur-an support family planning?
  458. A double-blind comparison of two oral contraceptives containing 50 mcg and 30 mcg ethinyl estradiol.
  459. Dr. Sheldon Segal: birth control updated.
  460. Drugs affecting oral contraceptives.
  461. Drugs and reference values in biology: 1. oral contraceptives. [Medicaments et valeurs de reference en biologie: 1. contraceptifs oraux.]
  462. Drugs, alcohol, and family planning. Sociopsychiatric viewpoints. [Drogen, Alkohol und Familienplanung. Sozialpsychiatrische Gesichtspunkte.]
  463. Dual regimen promising as male contraceptive.
  464. Duration of oral contraceptive therapy.
  465. E. coli septicemia in pregnancy associated with the shield intrauterine contraceptive device.
  466. Early abortion in a family planning clinic.
  467. Early postpartum and immediate postabortion intrauterine contraceptive device insertion.
  468. Early teenage pregnancy, contraception, and repeat pregnancy.
  469. Economic evaluation of family planning programmes: some problems and possibilities of analysis.
  470. Economic trade-offs and quality of life as related to family planning and population size.
  471. Ectopic pregnancy and the intrauterine contraceptive device.
  472. Ecuador officially adopts family planning.
  473. Editorial (oral contraception)
  474. Education and family planning. [Educacion y planificacion familiar.]
  475. EEG abnormalities found in healthy women under contraceptive medication. II. Long term studies.
  476. The effect in vitro of the steroidal component of oral contraceptives on platelet aggregation.
  477. Effect of a once weekly oral contraceptive upon gonadotrophin and gonadal steroid levels.
  478. The effect of an intrauterine copper contraceptive device on the uptake of tritiated-6, 7, oestradiol-17beta "in vivo" and of tritiated-5-uridine "in vitro" by the rat uterus.
  479. Effect of an oral contraceptive drug on non-arteriosclerotic, male and female virgin rats vs. arteriosclerotic, male and female breeder rats.
  480. Effect of an oral contraceptive on spontaneous activity of female rats.
  481. Effect of androgen-dominant and estrogen-dominant oral contraceptives on acne.
  482. The effect of contraception and its teaching on unwanted pregnancies in single girls: the U.K. experience.
  483. Effect of contraception on lactation.
  484. Effect of contraception on lactation.
  485. The effect of contraceptive steroids on carbohydrate metabolism. (Letter to the editor)
  486. Effect of contraceptive steroids on the fine structure of the guinea pig endometrial stromal cell. (Abstract only)
  487. The effect of education and significant others upon the contraceptive behaviour of married men.
  488. The effect of estrogen-progestogen oral contraceptives on blood pressure and on the renin-angiotensin-aldosterone system.
  489. Effect of hormonal contraceptives of various compositions on insulin secretion and carbohydrate tolerance. [Die Wirkung von unterschiedlich zusammengesetzten hormonalen Kontrazeptiva auf Insulinsekretion und Kohlenhydrattoleranz.]
  490. The effect of long-term oral treatment of rats with contraceptive steroids on tissue MAO.
  491. The effect of low tone motivational campaign on knowledge, opinion and practice of family planning.
  492. Effect of oral contraception on fibrin formation and dissolution.
  493. Effect of oral contraceptive agents and mineral vitamin supplementation on essential metal metabolism during menstrual cycle.
  494. Effect of oral contraceptive pills on the level of creatine phosphokinase with regard to carrier detection in Duchenne muscular dystrophy.
  495. The effect of oral contraceptive steroid therapy on the urinary metabolites of radioactive estrone and estradiol-17beta.
  496. Effect of oral contraceptive therapy on vitamin-A blood levels, vitamin-D3 and drug metabolism.
  497. Effect of oral contraceptives on acne.
  498. Effect of oral contraceptives on body water and electrolytes.
  499. Effect of oral contraceptives on drug and Vitamin D3 metabolism.
  500. Effect of oral contraceptives on drug metabolism in humans and rats.
  501. Effect of oral contraceptives on drug metabolism.
  502. The effect of oral contraceptives on hormonal cytology.
  503. Effect of oral contraceptives on quantity and quality of milk secretion in human beings.
  504. Effect of oral contraceptives on serum magnesium levels.
  505. Effect of oral contraceptives on the mammary glands of rhesus monkeys: a preliminary report.
  506. Effect of oral contraceptives on the peripheral vasculature of women.
  507. Effect of oral contraceptives on the plasma concentration of pyridoxal phosphate.
  508. Effect of oral contraceptives on the skin and their use in dermatology. [Dzialanie doustnych srodkow antykoncepcyjnych na skore i ich zastosowanie w dermatologii.]
  509. Effect of prolonged use of oral contraceptive drugs on the motor performance of healthy women.
  510. Effect of some oral contraceptives on the response of mice to pentobarbitone.
  511. Effect of steroid contraceptives upon gonadotrophins and gonadal steroids.
  512. The effect of synthetic FSH-LH/RH on plasma FSH, LH and 17beta-estradiol in women under oral contraception.
  513. Effect of the contraceptive Ovosiston on hirsutism. [Die Beeinflussung des Hirsutismus mit dem Kontrazeptivum Ovosiston.]
  514. Effect of various hormonal contraceptives on phagocytic activity of the reticuloendothelial system. [Die Wirkung verschiedener hormonal Antikonzeptiva auf die Phagozytosefah igkeit des Reticuloendothelialen Systems.]
  515. Effect on unwanted fertility of extending physician-administered birth control in the United States.
  516. Effectively strengthen party leadership over the work of family planning.
  517. Effectively strengthened party leadership over the work of family planning.
  518. Effectiveness of the antenatal clinic in the post-partum approach to family planning.
  519. Effects of a copper intrauterine contraceptive device on embryo survival, uterine spermicidal activity, and endometrial vascular porosity in the ewe.
  520. Effects of a low-estrogen oral contraceptive on urinary excretion of luteinizing hormone and ovarian steroids.
  521. The effects of a woman's perception of the legitimacy of family planning on resistance.
  522. Effects of an Oral-Contraceptive Agent on serum proteins, iron, and other Hematological parameters in healthy women.
  523. Effects of chronic administration of contraceptive steroids on biological age of rat ovarian cycles after stopping treatment) (Abstract only. [Effets de l'administration chronique de steroides anticonceptionnels sur l'age biologique des cycles ovariens de la ratte apres arret du traitement.]
  524. The effects of contraceptive steroids on carbohydrate metabolism: reply. (Letter to the editor)
  525. Effects of different oral contraceptives (combined and mini pill) on lipid metabolism.
  526. The effects of hormonal contraceptives on the human periodontium.
  527. Effects of increasing doses of oral-contraceptives on surface-tension and chemical composition of pulmonary surfactant and blood phospholipids in guinea-pigs.
  528. Effects of long-term administration of contraceptive steroids on fertility of female golden hamsters and their offspring. [Retentissements de l'administration prolongee de steroides anti-ovulatoires sur la fertilite du hamster dore femelle et de sa descendance.]
  529. The effects of long-term usage of oral contraceptive steroid drugs on Vitamin A, beta carotene, ascorbic acid, riboflavin and niacin in women. (Abstract only)
  530. The effects of mechanical and steroid contraceptive methods on blood pressure in hypertensive women.
  531. The effects of motivations for and instrumentality of family planning on resistance.
  532. Effects of oral contraceptive steroids on nutritional status of low income women. (Abstract only)
  533. Effects of oral contraceptives on endogenous hormone secretion.
  534. Effects of oral contraceptives on endogenous hormone secretion. (Letter)
  535. Effects of oral contraceptives on nerve conduction in the sural nerve. (Abstract only)
  536. The effects of oral contraceptives on the results of laboratory tests.
  537. Effects of oral contraceptives on the vascular system. (Abstract only)
  538. Effects of oral contraceptives on vitamin A metabolism in the human and the rat.
  539. The effects of personal efficacy on resistance to family planning.
  540. Effects of surgical contraception on sexual behavior.
  541. The effects of the educational process on the attitudes of physicians towards family planning.
  542. Effects or oral contraceptive steroids on enzymes of carbohydrate metabolism in extracts of human endometrium.
  543. El Salvador country report: a management oriented description of its family planning programs.
  544. El Salvador intensifies its family planning. [El Salvador intensifie son planning familial.]
  545. El Salvador sums up family planning success; plan enters new phase.
  546. Electrocardiographic changes during intrauterine contraceptive device insertion.
  547. Electroencephalographic changes in women treated with contraceptive steroids.
  548. Electroencephalographic correlates of endocrine changes induced by contraceptive steroids in humans.
  549. Elevation of plasma neurophysin in women on oral contraceptives.
  550. The employed woman: family planning and career.
  551. Endometrial reaction with long use of intrauterine contraceptive devices (7-9 years)
  552. Enhancement of hypertension by contraceptive steroids in a rat model.
  553. Erythema nodosum and oral contraceptives.
  554. Erythema nodosum and oral contraceptives. [Erytheme noyeux et contraceptifs oraux.]
  555. Establishment of sperm banks for contraceptive purpose.) (Letter to the editor. [Oprettelse af spermabank i antikonceptionelt ojemed.]
  556. Estimating the need for family planning services among unwed teenagers.
  557. Estradiol pellet implantation for contraception.
  558. Ethnic group and welfare status of women sterilized in federally funded family planning programs, 1972.
  559. Ethynodiol diacetate as a contraceptive.
  560. Evaluation machinery of family planning programme in India.
  561. Evaluation of a contraceptive without estrogens--exlutona. [Zur beurteilung eines kontrazeptivums ohne ostrogene--exlutona.]
  562. Factors influencing family planning program performance in India.
  563. Factors influencing lowered fe